Relationship Between Evolution of Resting Energy Expenditure and Tumoral Response to Chemotherapy in Patients Suffering From Pancreas Cancer
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Metastatic Pancreatic Cancer
Related studies linked through entity extraction aliases.
Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE2
Project Survival-Prospective Biomarker Discovery
- Status
- UNKNOWN
- Phase
- N/A
A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program
- Status
- COMPLETED
- Phase
- N/A
Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Pancreatic Cancer With Abraxane
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE3
ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem
- Status
- COMPLETED
- Phase
- PHASE2
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Improving Informed Consent for Palliative Chemotherapy
- Status
- COMPLETED
- Phase
- NA
Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas
- Status
- WITHDRAWN
- Phase
- N/A
Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2